Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 4.58B 685M 611M 566M 515M 966M 64.98B 982M 6.79B 2.67B 33.96B 2.57B 2.52B 109B P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 4.41B 660M 588M 545M 496M 930M 62.59B 945M 6.54B 2.57B 32.71B 2.48B 2.43B 105B EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day-3.67%
1 week-10.35%
Current month-17.57%
1 month-5.06%
3 months+1.29%
6 months-21.83%
Current year-0.76%
1 week 7.72
Extreme 7.72
8.75
1 month 7.72
Extreme 7.72
10.43
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.38
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
14.86
Manager TitleAgeSince
Chief Executive Officer 42 2017-12-10
Director of Finance/CFO 34 2019-07-31
Chief Operating Officer 45 2022-08-24
Director TitleAgeSince
Chairman 42 2019-07-31
Chairman 48 2019-03-20
Director/Board Member 46 2019-03-20
Date Insider Type Main position Quantity % Market Cap. Importance
8/7/26 Sell

Executive/Senior Manager

-2,000 0.0005%
9/14/21 Sell

Executive/Senior Manager

10,000 0.0025%
9/10/21 Sell

Executive/Senior Manager

77,000 0.0189%
Change 5-day change 1-year change 3-year change Capi.($)
-3.67%-10.35%-8.05%+14.87% 685M
-1.33%+4.88%+54.50%+109.94% 1,106B
-0.69%-3.77%+31.35%+66.62% 612B
-0.96%+0.55%+23.13%+94.26% 500B
+0.24%+5.58%+33.98%+59.40% 367B
-1.59%-1.25%+69.39%+43.02% 354B
-0.40%+3.53%+19.17%+46.55% 286B
-0.37%+3.11%-1.26%+18.23% 256B
-1.75%+1.76%+42.21%+51.44% 230B
-2.00%+1.75%+24.64%+95.14% 190B
Average -1.25%+1.00%+28.91%+59.95% 390.08B
Weighted average by Cap. -0.98%+2.30%+37.83%+75.45%

Financials

2024 2025
Net sales 984M 147M 131M 121M 110M 207M 13.94B 211M 1.46B 573M 7.29B 552M 540M 23.3B 1.21B 180M 161M 149M 135M 254M 17.09B 258M 1.79B 702M 8.93B 676M 662M 28.55B
Net income 13.65M 2.04M 1.82M 1.69M 1.53M 2.88M 194M 2.92M 20.22M 7.95M 101M 7.66M 7.5M 323M 92.73M 13.87M 12.36M 11.45M 10.41M 19.54M 1.31B 19.86M 137M 54.01M 687M 52.03M 50.94M 2.2B
Net Debt 189M 28.27M 25.2M 23.35M 21.23M 39.83M 2.68B 40.49M 280M 110M 1.4B 106M 104M 4.48B -169M -25.24M -22.5M -20.84M -18.95M -35.56M -2.39B -36.15M -250M -98.31M -1.25B -94.71M -92.73M -4B
Projected Income Statement - Annual - Beijing Beilu Pharmaceutical Co., Ltd.
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
26-10-19 CN¥7.880 -3.67% 33,498,067
26-10-16 CN¥8.180 -1.21% 43,976,450
26-10-15 CN¥8.280 -0.72% 35,122,233
26-10-14 CN¥8.340 -3.81% 22,942,600
26-10-13 CN¥8.670 -1.37% 25,195,614

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Beijing Beilu Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 300016 Stock